Marizyme Inc ($MRZM) - buy or sell? Stock discussion, ideas, forum

Marizyme Inc

Marizyme, Inc.

Industry: Systems Software

Ticker	Exchange	ISIN
$MRZM	OTC	US5703721028

Recent news

Synacor, Inc. reports 33.2% revenue decline in FY2020

BSQUARE Corporation reports 20.5% revenue decline in 2020 and 11.3 pp EBITDA Margin growth from -12.5% to -1.2%

eMagin Corporation CAPEX surged on 125% and Revenue jumped on 10.1%

Viveve Medical, Inc. reports 28.2% CAPEX decline in 2020 and 16.6% Revenue decline

Canadian Solar Inc. Debt jumped on 22.2% and Revenue increased on 8.6%

SMTC Corporation Debt increased on 5.4% while EBITDA decreased on 3.8%

SharpSpring, Inc. revenue growth accelerated from 21.7% in FY2019 to 29.0% in FY2020

Interlink Electronics, Inc. reports 8.1 pp EBITDA Margin growth from -2.3% to 5.9% in 2020 in 2020 while 5.7% Revenue decline

Intellicheck, Inc. Net Income jumped on 122% and Revenue jumped on 40.1%

VirnetX Holding Corp revenue jumped on 355,942% and EBITDA Margin surged on 23,179 pp from -23,127% to 52.2%

Twit about MRZM stock

Share your investment idea or question on Marizyme Inc stock:

Latest twits on Marizyme Inc (MRZM)

No twits yet. Be the first to post!

Have a question about MRZM? Ask and other investors will be eager to help you.

Have an idea about MRZM? Share it with other investors.

Marizyme Inc stock price chart

Marizyme Inc financials

mln. $	FY2012	FY2015	FY2016

Revenue	31.942	0.408	0.291
EBITDA	-4.303	0.000	-0.182
Net income	-12.648	-9.048	-0.873
CAPEX	1.623	0.000	0.000
Debt	1.401	0.347	0.000
Cash	1.503	0.014	0.012

About Marizyme Inc

Marizyme, Inc. operates as a holding company. The Company, through its subsidiaries, engages in the software development and technology consulting businesses. Marizyme serves customers worldwide.